International Bioscience Commercialization Consortium entered the industry of Associations in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 813910, which describes it as a Associations. For further clarification, the SIC classifies this business under the code 8611 and described it as a Associations. The business provides service to the B2B market.
To acquire more information, please contact James Walbom by calling (602) 343-8838 during business hours. You can also write to the business’ Single Location at 445 North 5th St # 600, Phoenix, Arizona AZ 85004. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | International Bioscience Commercialization Consortium |
| Representative: | James Walbom |
| Place of Business: | 445 North 5th St # 600, Phoenix, AZ 85004 |
| Contact Number: | (602) 343-8838 |
| Type of Service: | Associations |
| SIC Number: | 8611 |
| NAICS Number: | 813910 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2010 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
International Bioscience Commercialization Consortium is a company operating from Maricopa, Arizona providing professional Associations and relevant B2B variables. It was founded in 2010 and registered with the SIC code 8611 as Associations, and with the NAICS code 813910 as Associations.
With a current employee count of 1 to 4, International Bioscience Commercialization Consortium has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative James Walbom at (602) 343-8838 for related queries, or to locate its Single Location using the coordinates 33.451851,-112.067291.
The Single Location can also be found at the street address 445 North 5th St # 600 in Phoenix, Arizona 85004 and can be engaged online through the company website at , the company Twitter , and Facebook page .